Cargando…
Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach
Autores principales: | Archibugi, Livia, Capurso, Gabriele, Canto, Marcia Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083457/ https://www.ncbi.nlm.nih.gov/pubmed/36938945 http://dx.doi.org/10.1002/ueg2.12380 |
Ejemplares similares
-
Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta‐analysis with pre and post‐test probability assessment
por: Capurso, Gabriele, et al.
Publicado: (2023) -
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
por: Michl, Patrick, et al.
Publicado: (2021) -
Risk factors for the occurrence of ampullary tumors: A case‐control study
por: Zaccari, Piera, et al.
Publicado: (2022) -
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2018) -
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
por: Yu, Jun, et al.
Publicado: (2017)